Is clindamycin 300 mg orally three times daily plus linezolid 600 mg orally twice daily for 7–10 days appropriate for a superficial abdominal skin abscess with suspected MRSA?

This Regimen is NOT Appropriate – Use Monotherapy Instead

For a superficial abdominal skin abscess with suspected MRSA, you should NOT use both clindamycin 300 mg TID and linezolid 600 mg BID together. This combination is unnecessary, potentially harmful, and not supported by any guideline or evidence. Choose ONE appropriate MRSA-active antibiotic as monotherapy.

Why This Combination is Wrong

Dual therapy with clindamycin plus linezolid has no established role in treating uncomplicated skin abscesses. The IDSA guidelines explicitly recommend single-agent therapy for outpatient MRSA skin infections 1. Using two antibiotics simultaneously:

• Increases toxicity risk without improving efficacy
• Exposes the patient to unnecessary side effects (diarrhea, C. difficile, bone marrow suppression, neuropathy)
• Increases cost substantially
• Promotes antibiotic resistance

The Correct Approach

Step 1: Determine if Antibiotics Are Even Needed

Incision and drainage (I&D) is the primary treatment 1. For simple abscesses, I&D alone may be sufficient.

Add antibiotics ONLY if the patient has 1:

• Severe/extensive disease (multiple sites)
• Rapid progression with associated cellulitis
• Systemic illness signs (fever, tachycardia)
• Comorbidities or immunosuppression
• Extremes of age
• Difficult-to-drain location (face, hand, genitalia)
• Failed I&D alone

Step 2: If Antibiotics Are Indicated, Choose ONE Agent

For outpatient MRSA coverage, select ONE of the following 1:

First-line options:

• Clindamycin 300-450 mg PO TID (A-II evidence)
• TMP-SMX 1-2 double-strength tablets PO BID (A-II evidence)
• Doxycycline 100 mg PO BID (A-II evidence)

Alternative (more expensive, reserve for specific situations):

• Linezolid 600 mg PO BID (A-II evidence)

Step 3: Dosing Corrections for Your Proposed Regimen

If you choose clindamycin alone:

• Correct dose: 300-450 mg PO TID (not 300 mg TID plus anything else)
• Your 300 mg TID dosing is acceptable but on the lower end

If you choose linezolid alone:

• Correct dose: 600 mg PO BID (appropriate)
• Duration: 7-10 days is correct 1

Duration of Therapy

5-10 days is recommended 1, individualized based on clinical response. Your proposed 7-10 days falls within this range and is appropriate.

Critical Pitfalls to Avoid

1. Don't combine MRSA-active antibiotics without specific indication – There is no evidence supporting dual therapy for uncomplicated abscesses
2. Don't use clindamycin if local resistance >10% 1 – Check your institution's antibiogram
3. Don't forget I&D – Antibiotics are adjunctive; drainage is primary treatment 1
4. Don't use linezolid as first-line – Reserve for situations where other agents are contraindicated or have failed 1

Evidence Quality Note

The IDSA guidelines 1 consistently recommend monotherapy with equal strength of evidence (A-II) for clindamycin, TMP-SMX, tetracyclines, and linezolid. Recent research confirms TMP-SMX and clindamycin have similar efficacy for wound infections 2, with clindamycin showing slightly lower recurrence rates. There is no evidence supporting combination therapy for uncomplicated abscesses.

Bottom line: Choose clindamycin 300-450 mg PO TID OR linezolid 600 mg PO BID for 7-10 days – never both together.